Correlation Between Sonnet Biotherapeutics and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Fortress Biotech, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Fortress Biotech.

Diversification Opportunities for Sonnet Biotherapeutics and Fortress Biotech

0.38

Correlation Coefficient

Sonnet Biotherapeutics  Fortress Biotech

Weak diversification

The 3 months correlation between Sonnet and Fortress is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Fortress Biotech go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Fortress Biotech

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 1.39 times more return on investment than Fortress Biotech. However, Sonnet Biotherapeutics is 1.39 times more volatile than Fortress Biotech. It trades about 0.02 of its potential returns per unit of risk. Fortress Biotech is currently generating about 0.01 per unit of risk. If you would invest  144.00  in Sonnet Biotherapeutics Holdings on December 21, 2024 and sell it today you would lose (1.00) from holding Sonnet Biotherapeutics Holdings or give up 0.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  Fortress Biotech

Sonnet Biotherapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Fortress Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fortress Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Fortress Biotech is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Sonnet Biotherapeutics and Fortress Biotech

The main advantage of trading using opposite Sonnet Biotherapeutics and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind Sonnet Biotherapeutics Holdings and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.